Global Tasimelteon Market Growth (Status and Outlook) 2026-2032
The global Tasimelteon market size is predicted to grow from US$ 104 million in 2025 to US$ 115 million in 2032; it is expected to grow at a CAGR of 1.5% from 2026 to 2032.
Tasimelteon is a selective melatonin MT1 and MT2 receptor agonist used primarily for Non-24-Hour Sleep-Wake Disorder in adults and nighttime sleep disturbances associated with Smith-Magenis syndrome. It improves sleep timing and continuity through circadian rhythm regulation rather than conventional central nervous system sedation. Commercial dosage forms mainly include 20 mg capsules and a 4 mg/mL oral suspension. Upstream inputs include tasimelteon active pharmaceutical ingredient, capsule shells, fillers, suspending agents, thickeners, sweeteners, buffers, pharmaceutical bottles, and dosing devices. Downstream customers mainly include sleep medicine centers, neurology departments, genetic disorder specialists, pediatric departments, specialty pharmacies, hospital pharmacies, and regulated pharmaceutical distributors. The treated patient population is relatively small and requires specialist diagnosis, and the market consists mainly of the originator brand and a limited number of U.S. generic manufacturers, with an overall gross margin generally ranging from approximately 68% to 85%.
From the current market perspective, tasimelteon is primarily used for Non-24-Hour Sleep-Wake Disorder and nighttime sleep disturbances associated with Smith-Magenis syndrome. The addressable patient population is relatively limited, giving the market clear rare-disease and specialty-drug characteristics. Commercial demand is concentrated mainly in the United States, where the originator product retains advantages through indication coverage, a pediatric oral suspension, specialty pharmacy access, and patient support services, while the adult capsule segment has entered generic competition. Diagnosis depends heavily on sleep medicine, neurology, and genetic disorder specialists, resulting in a highly concentrated prescribing and distribution structure.
Looking ahead, the adult capsule segment will remain exposed to generic substitution and pricing pressure, while growth opportunities for the originator will increasingly depend on pediatric formulations, broader treatment coverage in Smith-Magenis syndrome, and development in additional circadian rhythm disorders. Oral suspension, weight-based dosing, and adherence support are expected to remain important areas of differentiation. Wider use of circadian rhythm monitoring, digital follow-up tools, and telemedicine may also improve patient identification, treatment assessment, and long-term therapy management.
Key market drivers include improving awareness of Non-24 among totally blind individuals, expansion of specialist sleep medicine services, and better diagnosis of rare genetic disorders. Patients with Smith-Magenis syndrome often require long-term management of sleep disturbances, and tasimelteon's defined receptor target and circadian rhythm mechanism support its role in structured specialist treatment. In addition, tasimelteon is not a conventional controlled sedative-hypnotic and carries a comparatively lower burden related to dependence and abuse management, which supports continued use under specialist supervision.
The main constraints include a narrow eligible patient population and a complex process of patient identification, diagnosis, and referral. High branded treatment costs, insurance access requirements, prior authorization, and patient affordability can directly limit treatment uptake. As generic capsules gain share, prescription volume may continue to increase, but average selling prices and originator revenue are likely to remain under pressure. Lower-cost alternatives such as melatonin, the absence of immediate sedative effects, and the need for consistent long-term dosing may also influence treatment selection and adherence.
LPI (LP Information)' newest research report, the “Tasimelteon Industry Forecast” looks at past sales and reviews total world Tasimelteon sales in 2025, providing a comprehensive analysis by region and market sector of projected Tasimelteon sales for 2026 through 2032. With Tasimelteon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tasimelteon industry.
This Insight Report provides a comprehensive analysis of the global Tasimelteon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tasimelteon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tasimelteon market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tasimelteon and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tasimelteon.
This report presents a comprehensive overview, market shares, and growth opportunities of Tasimelteon market by product type, application, key players and key regions and countries.
Tasimelteon is a selective melatonin MT1 and MT2 receptor agonist used primarily for Non-24-Hour Sleep-Wake Disorder in adults and nighttime sleep disturbances associated with Smith-Magenis syndrome. It improves sleep timing and continuity through circadian rhythm regulation rather than conventional central nervous system sedation. Commercial dosage forms mainly include 20 mg capsules and a 4 mg/mL oral suspension. Upstream inputs include tasimelteon active pharmaceutical ingredient, capsule shells, fillers, suspending agents, thickeners, sweeteners, buffers, pharmaceutical bottles, and dosing devices. Downstream customers mainly include sleep medicine centers, neurology departments, genetic disorder specialists, pediatric departments, specialty pharmacies, hospital pharmacies, and regulated pharmaceutical distributors. The treated patient population is relatively small and requires specialist diagnosis, and the market consists mainly of the originator brand and a limited number of U.S. generic manufacturers, with an overall gross margin generally ranging from approximately 68% to 85%.
From the current market perspective, tasimelteon is primarily used for Non-24-Hour Sleep-Wake Disorder and nighttime sleep disturbances associated with Smith-Magenis syndrome. The addressable patient population is relatively limited, giving the market clear rare-disease and specialty-drug characteristics. Commercial demand is concentrated mainly in the United States, where the originator product retains advantages through indication coverage, a pediatric oral suspension, specialty pharmacy access, and patient support services, while the adult capsule segment has entered generic competition. Diagnosis depends heavily on sleep medicine, neurology, and genetic disorder specialists, resulting in a highly concentrated prescribing and distribution structure.
Looking ahead, the adult capsule segment will remain exposed to generic substitution and pricing pressure, while growth opportunities for the originator will increasingly depend on pediatric formulations, broader treatment coverage in Smith-Magenis syndrome, and development in additional circadian rhythm disorders. Oral suspension, weight-based dosing, and adherence support are expected to remain important areas of differentiation. Wider use of circadian rhythm monitoring, digital follow-up tools, and telemedicine may also improve patient identification, treatment assessment, and long-term therapy management.
Key market drivers include improving awareness of Non-24 among totally blind individuals, expansion of specialist sleep medicine services, and better diagnosis of rare genetic disorders. Patients with Smith-Magenis syndrome often require long-term management of sleep disturbances, and tasimelteon's defined receptor target and circadian rhythm mechanism support its role in structured specialist treatment. In addition, tasimelteon is not a conventional controlled sedative-hypnotic and carries a comparatively lower burden related to dependence and abuse management, which supports continued use under specialist supervision.
The main constraints include a narrow eligible patient population and a complex process of patient identification, diagnosis, and referral. High branded treatment costs, insurance access requirements, prior authorization, and patient affordability can directly limit treatment uptake. As generic capsules gain share, prescription volume may continue to increase, but average selling prices and originator revenue are likely to remain under pressure. Lower-cost alternatives such as melatonin, the absence of immediate sedative effects, and the need for consistent long-term dosing may also influence treatment selection and adherence.
LPI (LP Information)' newest research report, the “Tasimelteon Industry Forecast” looks at past sales and reviews total world Tasimelteon sales in 2025, providing a comprehensive analysis by region and market sector of projected Tasimelteon sales for 2026 through 2032. With Tasimelteon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tasimelteon industry.
This Insight Report provides a comprehensive analysis of the global Tasimelteon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tasimelteon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tasimelteon market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tasimelteon and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tasimelteon.
This report presents a comprehensive overview, market shares, and growth opportunities of Tasimelteon market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Capsules
- Oral Suspension
Segmentation by Product Status:
- Originator Drug
- Generic Drugs
Segmentation by Patient Group:
- Adult Patients
- Pediatric Patients
Segmentation by Application:
- Hospital
- Clinic
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Vanda Pharmaceuticals
- Teva Pharmaceutical Industries
- Apotex
- MSN Laboratories
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tasimelteon Market Size (2021-2032)
2.1.2 Tasimelteon Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Tasimelteon by Country/Region (2021, 2025 & 2032)
2.2 Tasimelteon Segment by Type
2.2.1 Capsules
2.2.2 Oral Suspension
2.2.3 Tasimelteon Market Size by Type
2.2.3.1 Tasimelteon Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Tasimelteon Market Size Market Share by Type (2021-2026)
2.3 Tasimelteon Segment by Product Status
2.3.1 Originator Drug
2.3.2 Generic Drugs
2.3.3 Tasimelteon Market Size by Product Status
2.3.3.1 Tasimelteon Market Size CAGR by Product Status (2021 VS 2025 VS 2032)
2.3.3.2 Global Tasimelteon Market Size Market Share by Product Status (2021-2026)
2.4 Tasimelteon Segment by Patient Group
2.4.1 Adult Patients
2.4.2 Pediatric Patients
2.4.3 Tasimelteon Market Size by Patient Group
2.4.3.1 Tasimelteon Market Size CAGR by Patient Group (2021 VS 2025 VS 2032)
2.4.3.2 Global Tasimelteon Market Size Market Share by Patient Group (2021-2026)
2.5 Tasimelteon Segment by Application
2.5.1 Hospital
2.5.2 Clinic
2.5.3 Other
2.5.4 Tasimelteon Market Size by Application
2.5.4.1 Tasimelteon Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Tasimelteon Market Size Market Share by Application (2021-2026)
3 TASIMELTEON MARKET SIZE BY PLAYER
3.1 Tasimelteon Market Size Market Share by Player
3.1.1 Global Tasimelteon Revenue by Player (2021-2026)
3.1.2 Global Tasimelteon Revenue Market Share by Player (2021-2026)
3.2 Global Tasimelteon Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TASIMELTEON BY REGION
4.1 Tasimelteon Market Size by Region (2021-2026)
4.2 Global Tasimelteon Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tasimelteon Market Size Growth (2021-2026)
4.4 APAC Tasimelteon Market Size Growth (2021-2026)
4.5 Europe Tasimelteon Market Size Growth (2021-2026)
4.6 Middle East & Africa Tasimelteon Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Tasimelteon Market Size by Country (2021-2026)
5.2 Americas Tasimelteon Market Size by Type (2021-2026)
5.3 Americas Tasimelteon Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tasimelteon Market Size by Region (2021-2026)
6.2 APAC Tasimelteon Market Size by Type (2021-2026)
6.3 APAC Tasimelteon Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tasimelteon Market Size by Country (2021-2026)
7.2 Europe Tasimelteon Market Size by Type (2021-2026)
7.3 Europe Tasimelteon Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tasimelteon by Region (2021-2026)
8.2 Middle East & Africa Tasimelteon Market Size by Type (2021-2026)
8.3 Middle East & Africa Tasimelteon Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TASIMELTEON MARKET FORECAST
10.1 Global Tasimelteon Forecast by Region (2027-2032)
10.1.1 Global Tasimelteon Forecast by Region (2027-2032)
10.1.2 Americas Tasimelteon Forecast
10.1.3 APAC Tasimelteon Forecast
10.1.4 Europe Tasimelteon Forecast
10.1.5 Middle East & Africa Tasimelteon Forecast
10.2 Americas Tasimelteon Forecast by Country (2027-2032)
10.2.1 United States Market Tasimelteon Forecast
10.2.2 Canada Market Tasimelteon Forecast
10.2.3 Mexico Market Tasimelteon Forecast
10.2.4 Brazil Market Tasimelteon Forecast
10.3 APAC Tasimelteon Forecast by Region (2027-2032)
10.3.1 China Tasimelteon Market Forecast
10.3.2 Japan Market Tasimelteon Forecast
10.3.3 Korea Market Tasimelteon Forecast
10.3.4 Southeast Asia Market Tasimelteon Forecast
10.3.5 India Market Tasimelteon Forecast
10.3.6 Australia Market Tasimelteon Forecast
10.4 Europe Tasimelteon Forecast by Country (2027-2032)
10.4.1 Germany Market Tasimelteon Forecast
10.4.2 France Market Tasimelteon Forecast
10.4.3 UK Market Tasimelteon Forecast
10.4.4 Italy Market Tasimelteon Forecast
10.4.5 Russia Market Tasimelteon Forecast
10.5 Middle East & Africa Tasimelteon Forecast by Region (2027-2032)
10.5.1 Egypt Market Tasimelteon Forecast
10.5.2 South Africa Market Tasimelteon Forecast
10.5.3 Israel Market Tasimelteon Forecast
10.5.4 Turkey Market Tasimelteon Forecast
10.6 Global Tasimelteon Forecast by Type (2027-2032)
10.7 Global Tasimelteon Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Tasimelteon Forecast
11 KEY PLAYERS ANALYSIS
11.1 Vanda Pharmaceuticals
11.1.1 Vanda Pharmaceuticals Company Information
11.1.2 Vanda Pharmaceuticals Tasimelteon Product Offered
11.1.3 Vanda Pharmaceuticals Tasimelteon Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Vanda Pharmaceuticals Main Business Overview
11.1.5 Vanda Pharmaceuticals Latest Developments
11.2 Teva Pharmaceutical Industries
11.2.1 Teva Pharmaceutical Industries Company Information
11.2.2 Teva Pharmaceutical Industries Tasimelteon Product Offered
11.2.3 Teva Pharmaceutical Industries Tasimelteon Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Teva Pharmaceutical Industries Main Business Overview
11.2.5 Teva Pharmaceutical Industries Latest Developments
11.3 Apotex
11.3.1 Apotex Company Information
11.3.2 Apotex Tasimelteon Product Offered
11.3.3 Apotex Tasimelteon Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Apotex Main Business Overview
11.3.5 Apotex Latest Developments
11.4 MSN Laboratories
11.4.1 MSN Laboratories Company Information
11.4.2 MSN Laboratories Tasimelteon Product Offered
11.4.3 MSN Laboratories Tasimelteon Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 MSN Laboratories Main Business Overview
11.4.5 MSN Laboratories Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tasimelteon Market Size (2021-2032)
2.1.2 Tasimelteon Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Tasimelteon by Country/Region (2021, 2025 & 2032)
2.2 Tasimelteon Segment by Type
2.2.1 Capsules
2.2.2 Oral Suspension
2.2.3 Tasimelteon Market Size by Type
2.2.3.1 Tasimelteon Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Tasimelteon Market Size Market Share by Type (2021-2026)
2.3 Tasimelteon Segment by Product Status
2.3.1 Originator Drug
2.3.2 Generic Drugs
2.3.3 Tasimelteon Market Size by Product Status
2.3.3.1 Tasimelteon Market Size CAGR by Product Status (2021 VS 2025 VS 2032)
2.3.3.2 Global Tasimelteon Market Size Market Share by Product Status (2021-2026)
2.4 Tasimelteon Segment by Patient Group
2.4.1 Adult Patients
2.4.2 Pediatric Patients
2.4.3 Tasimelteon Market Size by Patient Group
2.4.3.1 Tasimelteon Market Size CAGR by Patient Group (2021 VS 2025 VS 2032)
2.4.3.2 Global Tasimelteon Market Size Market Share by Patient Group (2021-2026)
2.5 Tasimelteon Segment by Application
2.5.1 Hospital
2.5.2 Clinic
2.5.3 Other
2.5.4 Tasimelteon Market Size by Application
2.5.4.1 Tasimelteon Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Tasimelteon Market Size Market Share by Application (2021-2026)
3 TASIMELTEON MARKET SIZE BY PLAYER
3.1 Tasimelteon Market Size Market Share by Player
3.1.1 Global Tasimelteon Revenue by Player (2021-2026)
3.1.2 Global Tasimelteon Revenue Market Share by Player (2021-2026)
3.2 Global Tasimelteon Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TASIMELTEON BY REGION
4.1 Tasimelteon Market Size by Region (2021-2026)
4.2 Global Tasimelteon Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tasimelteon Market Size Growth (2021-2026)
4.4 APAC Tasimelteon Market Size Growth (2021-2026)
4.5 Europe Tasimelteon Market Size Growth (2021-2026)
4.6 Middle East & Africa Tasimelteon Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Tasimelteon Market Size by Country (2021-2026)
5.2 Americas Tasimelteon Market Size by Type (2021-2026)
5.3 Americas Tasimelteon Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tasimelteon Market Size by Region (2021-2026)
6.2 APAC Tasimelteon Market Size by Type (2021-2026)
6.3 APAC Tasimelteon Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tasimelteon Market Size by Country (2021-2026)
7.2 Europe Tasimelteon Market Size by Type (2021-2026)
7.3 Europe Tasimelteon Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tasimelteon by Region (2021-2026)
8.2 Middle East & Africa Tasimelteon Market Size by Type (2021-2026)
8.3 Middle East & Africa Tasimelteon Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TASIMELTEON MARKET FORECAST
10.1 Global Tasimelteon Forecast by Region (2027-2032)
10.1.1 Global Tasimelteon Forecast by Region (2027-2032)
10.1.2 Americas Tasimelteon Forecast
10.1.3 APAC Tasimelteon Forecast
10.1.4 Europe Tasimelteon Forecast
10.1.5 Middle East & Africa Tasimelteon Forecast
10.2 Americas Tasimelteon Forecast by Country (2027-2032)
10.2.1 United States Market Tasimelteon Forecast
10.2.2 Canada Market Tasimelteon Forecast
10.2.3 Mexico Market Tasimelteon Forecast
10.2.4 Brazil Market Tasimelteon Forecast
10.3 APAC Tasimelteon Forecast by Region (2027-2032)
10.3.1 China Tasimelteon Market Forecast
10.3.2 Japan Market Tasimelteon Forecast
10.3.3 Korea Market Tasimelteon Forecast
10.3.4 Southeast Asia Market Tasimelteon Forecast
10.3.5 India Market Tasimelteon Forecast
10.3.6 Australia Market Tasimelteon Forecast
10.4 Europe Tasimelteon Forecast by Country (2027-2032)
10.4.1 Germany Market Tasimelteon Forecast
10.4.2 France Market Tasimelteon Forecast
10.4.3 UK Market Tasimelteon Forecast
10.4.4 Italy Market Tasimelteon Forecast
10.4.5 Russia Market Tasimelteon Forecast
10.5 Middle East & Africa Tasimelteon Forecast by Region (2027-2032)
10.5.1 Egypt Market Tasimelteon Forecast
10.5.2 South Africa Market Tasimelteon Forecast
10.5.3 Israel Market Tasimelteon Forecast
10.5.4 Turkey Market Tasimelteon Forecast
10.6 Global Tasimelteon Forecast by Type (2027-2032)
10.7 Global Tasimelteon Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Tasimelteon Forecast
11 KEY PLAYERS ANALYSIS
11.1 Vanda Pharmaceuticals
11.1.1 Vanda Pharmaceuticals Company Information
11.1.2 Vanda Pharmaceuticals Tasimelteon Product Offered
11.1.3 Vanda Pharmaceuticals Tasimelteon Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Vanda Pharmaceuticals Main Business Overview
11.1.5 Vanda Pharmaceuticals Latest Developments
11.2 Teva Pharmaceutical Industries
11.2.1 Teva Pharmaceutical Industries Company Information
11.2.2 Teva Pharmaceutical Industries Tasimelteon Product Offered
11.2.3 Teva Pharmaceutical Industries Tasimelteon Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Teva Pharmaceutical Industries Main Business Overview
11.2.5 Teva Pharmaceutical Industries Latest Developments
11.3 Apotex
11.3.1 Apotex Company Information
11.3.2 Apotex Tasimelteon Product Offered
11.3.3 Apotex Tasimelteon Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Apotex Main Business Overview
11.3.5 Apotex Latest Developments
11.4 MSN Laboratories
11.4.1 MSN Laboratories Company Information
11.4.2 MSN Laboratories Tasimelteon Product Offered
11.4.3 MSN Laboratories Tasimelteon Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 MSN Laboratories Main Business Overview
11.4.5 MSN Laboratories Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tasimelteon Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Tasimelteon Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Capsules
Table 4. Major Players of Oral Suspension
Table 5. Tasimelteon Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Tasimelteon Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Tasimelteon Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Originator Drug
Table 9. Major Players of Generic Drugs
Table 10. Tasimelteon Market Size CAGR by Product Status (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Tasimelteon Market Size by Product Status (2021-2026) & ($ millions)
Table 12. Global Tasimelteon Market Size Market Share by Product Status (2021-2026)
Table 13. Major Players of Adult Patients
Table 14. Major Players of Pediatric Patients
Table 15. Tasimelteon Market Size CAGR by Patient Group (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Tasimelteon Market Size by Patient Group (2021-2026) & ($ millions)
Table 17. Global Tasimelteon Market Size Market Share by Patient Group (2021-2026)
Table 18. Tasimelteon Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Tasimelteon Market Size by Application (2021-2026) & ($ millions)
Table 20. Global Tasimelteon Market Size Market Share by Application (2021-2026)
Table 21. Global Tasimelteon Revenue by Player (2021-2026) & ($ millions)
Table 22. Global Tasimelteon Revenue Market Share by Player (2021-2026)
Table 23. Tasimelteon Key Players Head office and Products Offered
Table 24. Tasimelteon Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Tasimelteon Market Size by Region (2021-2026) & ($ millions)
Table 28. Global Tasimelteon Market Size Market Share by Region (2021-2026)
Table 29. Global Tasimelteon Revenue by Country/Region (2021-2026) & ($ millions)
Table 30. Global Tasimelteon Revenue Market Share by Country/Region (2021-2026)
Table 31. Americas Tasimelteon Market Size by Country (2021-2026) & ($ millions)
Table 32. Americas Tasimelteon Market Size Market Share by Country (2021-2026)
Table 33. Americas Tasimelteon Market Size by Type (2021-2026) & ($ millions)
Table 34. Americas Tasimelteon Market Size Market Share by Type (2021-2026)
Table 35. Americas Tasimelteon Market Size by Application (2021-2026) & ($ millions)
Table 36. Americas Tasimelteon Market Size Market Share by Application (2021-2026)
Table 37. APAC Tasimelteon Market Size by Region (2021-2026) & ($ millions)
Table 38. APAC Tasimelteon Market Size Market Share by Region (2021-2026)
Table 39. APAC Tasimelteon Market Size by Type (2021-2026) & ($ millions)
Table 40. APAC Tasimelteon Market Size by Application (2021-2026) & ($ millions)
Table 41. Europe Tasimelteon Market Size by Country (2021-2026) & ($ millions)
Table 42. Europe Tasimelteon Market Size Market Share by Country (2021-2026)
Table 43. Europe Tasimelteon Market Size by Type (2021-2026) & ($ millions)
Table 44. Europe Tasimelteon Market Size by Application (2021-2026) & ($ millions)
Table 45. Middle East & Africa Tasimelteon Market Size by Region (2021-2026) & ($ millions)
Table 46. Middle East & Africa Tasimelteon Market Size by Type (2021-2026) & ($ millions)
Table 47. Middle East & Africa Tasimelteon Market Size by Application (2021-2026) & ($ millions)
Table 48. Key Market Drivers & Growth Opportunities of Tasimelteon
Table 49. Key Market Challenges & Risks of Tasimelteon
Table 50. Key Industry Trends of Tasimelteon
Table 51. Global Tasimelteon Market Size Forecast by Region (2027-2032) & ($ millions)
Table 52. Global Tasimelteon Market Size Market Share Forecast by Region (2027-2032)
Table 53. Global Tasimelteon Market Size Forecast by Type (2027-2032) & ($ millions)
Table 54. Global Tasimelteon Market Size Forecast by Application (2027-2032) & ($ millions)
Table 55. Vanda Pharmaceuticals Details, Company Type, Tasimelteon Area Served and Its Competitors
Table 56. Vanda Pharmaceuticals Tasimelteon Product Offered
Table 57. Vanda Pharmaceuticals Tasimelteon Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Vanda Pharmaceuticals Main Business
Table 59. Vanda Pharmaceuticals Latest Developments
Table 60. Teva Pharmaceutical Industries Details, Company Type, Tasimelteon Area Served and Its Competitors
Table 61. Teva Pharmaceutical Industries Tasimelteon Product Offered
Table 62. Teva Pharmaceutical Industries Tasimelteon Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Teva Pharmaceutical Industries Main Business
Table 64. Teva Pharmaceutical Industries Latest Developments
Table 65. Apotex Details, Company Type, Tasimelteon Area Served and Its Competitors
Table 66. Apotex Tasimelteon Product Offered
Table 67. Apotex Tasimelteon Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Apotex Main Business
Table 69. Apotex Latest Developments
Table 70. MSN Laboratories Details, Company Type, Tasimelteon Area Served and Its Competitors
Table 71. MSN Laboratories Tasimelteon Product Offered
Table 72. MSN Laboratories Tasimelteon Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. MSN Laboratories Main Business
Table 74. MSN Laboratories Latest Developments
Table 1. Tasimelteon Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Tasimelteon Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Capsules
Table 4. Major Players of Oral Suspension
Table 5. Tasimelteon Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Tasimelteon Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Tasimelteon Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Originator Drug
Table 9. Major Players of Generic Drugs
Table 10. Tasimelteon Market Size CAGR by Product Status (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Tasimelteon Market Size by Product Status (2021-2026) & ($ millions)
Table 12. Global Tasimelteon Market Size Market Share by Product Status (2021-2026)
Table 13. Major Players of Adult Patients
Table 14. Major Players of Pediatric Patients
Table 15. Tasimelteon Market Size CAGR by Patient Group (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Tasimelteon Market Size by Patient Group (2021-2026) & ($ millions)
Table 17. Global Tasimelteon Market Size Market Share by Patient Group (2021-2026)
Table 18. Tasimelteon Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Tasimelteon Market Size by Application (2021-2026) & ($ millions)
Table 20. Global Tasimelteon Market Size Market Share by Application (2021-2026)
Table 21. Global Tasimelteon Revenue by Player (2021-2026) & ($ millions)
Table 22. Global Tasimelteon Revenue Market Share by Player (2021-2026)
Table 23. Tasimelteon Key Players Head office and Products Offered
Table 24. Tasimelteon Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Tasimelteon Market Size by Region (2021-2026) & ($ millions)
Table 28. Global Tasimelteon Market Size Market Share by Region (2021-2026)
Table 29. Global Tasimelteon Revenue by Country/Region (2021-2026) & ($ millions)
Table 30. Global Tasimelteon Revenue Market Share by Country/Region (2021-2026)
Table 31. Americas Tasimelteon Market Size by Country (2021-2026) & ($ millions)
Table 32. Americas Tasimelteon Market Size Market Share by Country (2021-2026)
Table 33. Americas Tasimelteon Market Size by Type (2021-2026) & ($ millions)
Table 34. Americas Tasimelteon Market Size Market Share by Type (2021-2026)
Table 35. Americas Tasimelteon Market Size by Application (2021-2026) & ($ millions)
Table 36. Americas Tasimelteon Market Size Market Share by Application (2021-2026)
Table 37. APAC Tasimelteon Market Size by Region (2021-2026) & ($ millions)
Table 38. APAC Tasimelteon Market Size Market Share by Region (2021-2026)
Table 39. APAC Tasimelteon Market Size by Type (2021-2026) & ($ millions)
Table 40. APAC Tasimelteon Market Size by Application (2021-2026) & ($ millions)
Table 41. Europe Tasimelteon Market Size by Country (2021-2026) & ($ millions)
Table 42. Europe Tasimelteon Market Size Market Share by Country (2021-2026)
Table 43. Europe Tasimelteon Market Size by Type (2021-2026) & ($ millions)
Table 44. Europe Tasimelteon Market Size by Application (2021-2026) & ($ millions)
Table 45. Middle East & Africa Tasimelteon Market Size by Region (2021-2026) & ($ millions)
Table 46. Middle East & Africa Tasimelteon Market Size by Type (2021-2026) & ($ millions)
Table 47. Middle East & Africa Tasimelteon Market Size by Application (2021-2026) & ($ millions)
Table 48. Key Market Drivers & Growth Opportunities of Tasimelteon
Table 49. Key Market Challenges & Risks of Tasimelteon
Table 50. Key Industry Trends of Tasimelteon
Table 51. Global Tasimelteon Market Size Forecast by Region (2027-2032) & ($ millions)
Table 52. Global Tasimelteon Market Size Market Share Forecast by Region (2027-2032)
Table 53. Global Tasimelteon Market Size Forecast by Type (2027-2032) & ($ millions)
Table 54. Global Tasimelteon Market Size Forecast by Application (2027-2032) & ($ millions)
Table 55. Vanda Pharmaceuticals Details, Company Type, Tasimelteon Area Served and Its Competitors
Table 56. Vanda Pharmaceuticals Tasimelteon Product Offered
Table 57. Vanda Pharmaceuticals Tasimelteon Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Vanda Pharmaceuticals Main Business
Table 59. Vanda Pharmaceuticals Latest Developments
Table 60. Teva Pharmaceutical Industries Details, Company Type, Tasimelteon Area Served and Its Competitors
Table 61. Teva Pharmaceutical Industries Tasimelteon Product Offered
Table 62. Teva Pharmaceutical Industries Tasimelteon Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Teva Pharmaceutical Industries Main Business
Table 64. Teva Pharmaceutical Industries Latest Developments
Table 65. Apotex Details, Company Type, Tasimelteon Area Served and Its Competitors
Table 66. Apotex Tasimelteon Product Offered
Table 67. Apotex Tasimelteon Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Apotex Main Business
Table 69. Apotex Latest Developments
Table 70. MSN Laboratories Details, Company Type, Tasimelteon Area Served and Its Competitors
Table 71. MSN Laboratories Tasimelteon Product Offered
Table 72. MSN Laboratories Tasimelteon Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. MSN Laboratories Main Business
Table 74. MSN Laboratories Latest Developments
LIST OF FIGURES
Figure 1. Tasimelteon Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tasimelteon Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Tasimelteon Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Tasimelteon Sales Market Share by Country/Region (2025)
Figure 8. Tasimelteon Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Tasimelteon Market Size Market Share by Type in 2025
Figure 10. Global Tasimelteon Market Size Market Share by Product Status in 2025
Figure 11. Global Tasimelteon Market Size Market Share by Patient Group in 2025
Figure 12. Tasimelteon in Hospital
Figure 13. Global Tasimelteon Market: Hospital (2021-2026) & ($ millions)
Figure 14. Tasimelteon in Clinic
Figure 15. Global Tasimelteon Market: Clinic (2021-2026) & ($ millions)
Figure 16. Tasimelteon in Other
Figure 17. Global Tasimelteon Market: Other (2021-2026) & ($ millions)
Figure 18. Global Tasimelteon Market Size Market Share by Application in 2025
Figure 19. Global Tasimelteon Revenue Market Share by Player in 2025
Figure 20. Global Tasimelteon Market Size Market Share by Region (2021-2026)
Figure 21. Americas Tasimelteon Market Size 2021-2026 ($ millions)
Figure 22. APAC Tasimelteon Market Size 2021-2026 ($ millions)
Figure 23. Europe Tasimelteon Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Tasimelteon Market Size 2021-2026 ($ millions)
Figure 25. Americas Tasimelteon Value Market Share by Country in 2025
Figure 26. United States Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Tasimelteon Market Size Market Share by Region in 2025
Figure 31. APAC Tasimelteon Market Size Market Share by Type (2021-2026)
Figure 32. APAC Tasimelteon Market Size Market Share by Application (2021-2026)
Figure 33. China Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 37. India Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Tasimelteon Market Size Market Share by Country in 2025
Figure 40. Europe Tasimelteon Market Size Market Share by Type (2021-2026)
Figure 41. Europe Tasimelteon Market Size Market Share by Application (2021-2026)
Figure 42. Germany Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 43. France Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Tasimelteon Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Tasimelteon Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Tasimelteon Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Tasimelteon Market Size 2027-2032 ($ millions)
Figure 56. APAC Tasimelteon Market Size 2027-2032 ($ millions)
Figure 57. Europe Tasimelteon Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Tasimelteon Market Size 2027-2032 ($ millions)
Figure 59. United States Tasimelteon Market Size 2027-2032 ($ millions)
Figure 60. Canada Tasimelteon Market Size 2027-2032 ($ millions)
Figure 61. Mexico Tasimelteon Market Size 2027-2032 ($ millions)
Figure 62. Brazil Tasimelteon Market Size 2027-2032 ($ millions)
Figure 63. China Tasimelteon Market Size 2027-2032 ($ millions)
Figure 64. Japan Tasimelteon Market Size 2027-2032 ($ millions)
Figure 65. Korea Tasimelteon Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Tasimelteon Market Size 2027-2032 ($ millions)
Figure 67. India Tasimelteon Market Size 2027-2032 ($ millions)
Figure 68. Australia Tasimelteon Market Size 2027-2032 ($ millions)
Figure 69. Germany Tasimelteon Market Size 2027-2032 ($ millions)
Figure 70. France Tasimelteon Market Size 2027-2032 ($ millions)
Figure 71. UK Tasimelteon Market Size 2027-2032 ($ millions)
Figure 72. Italy Tasimelteon Market Size 2027-2032 ($ millions)
Figure 73. Russia Tasimelteon Market Size 2027-2032 ($ millions)
Figure 74. Egypt Tasimelteon Market Size 2027-2032 ($ millions)
Figure 75. South Africa Tasimelteon Market Size 2027-2032 ($ millions)
Figure 76. Israel Tasimelteon Market Size 2027-2032 ($ millions)
Figure 77. Turkey Tasimelteon Market Size 2027-2032 ($ millions)
Figure 78. Global Tasimelteon Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Tasimelteon Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Tasimelteon Market Size 2027-2032 ($ millions)
Figure 1. Tasimelteon Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tasimelteon Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Tasimelteon Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Tasimelteon Sales Market Share by Country/Region (2025)
Figure 8. Tasimelteon Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Tasimelteon Market Size Market Share by Type in 2025
Figure 10. Global Tasimelteon Market Size Market Share by Product Status in 2025
Figure 11. Global Tasimelteon Market Size Market Share by Patient Group in 2025
Figure 12. Tasimelteon in Hospital
Figure 13. Global Tasimelteon Market: Hospital (2021-2026) & ($ millions)
Figure 14. Tasimelteon in Clinic
Figure 15. Global Tasimelteon Market: Clinic (2021-2026) & ($ millions)
Figure 16. Tasimelteon in Other
Figure 17. Global Tasimelteon Market: Other (2021-2026) & ($ millions)
Figure 18. Global Tasimelteon Market Size Market Share by Application in 2025
Figure 19. Global Tasimelteon Revenue Market Share by Player in 2025
Figure 20. Global Tasimelteon Market Size Market Share by Region (2021-2026)
Figure 21. Americas Tasimelteon Market Size 2021-2026 ($ millions)
Figure 22. APAC Tasimelteon Market Size 2021-2026 ($ millions)
Figure 23. Europe Tasimelteon Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Tasimelteon Market Size 2021-2026 ($ millions)
Figure 25. Americas Tasimelteon Value Market Share by Country in 2025
Figure 26. United States Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Tasimelteon Market Size Market Share by Region in 2025
Figure 31. APAC Tasimelteon Market Size Market Share by Type (2021-2026)
Figure 32. APAC Tasimelteon Market Size Market Share by Application (2021-2026)
Figure 33. China Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 37. India Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Tasimelteon Market Size Market Share by Country in 2025
Figure 40. Europe Tasimelteon Market Size Market Share by Type (2021-2026)
Figure 41. Europe Tasimelteon Market Size Market Share by Application (2021-2026)
Figure 42. Germany Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 43. France Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Tasimelteon Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Tasimelteon Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Tasimelteon Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Tasimelteon Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Tasimelteon Market Size 2027-2032 ($ millions)
Figure 56. APAC Tasimelteon Market Size 2027-2032 ($ millions)
Figure 57. Europe Tasimelteon Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Tasimelteon Market Size 2027-2032 ($ millions)
Figure 59. United States Tasimelteon Market Size 2027-2032 ($ millions)
Figure 60. Canada Tasimelteon Market Size 2027-2032 ($ millions)
Figure 61. Mexico Tasimelteon Market Size 2027-2032 ($ millions)
Figure 62. Brazil Tasimelteon Market Size 2027-2032 ($ millions)
Figure 63. China Tasimelteon Market Size 2027-2032 ($ millions)
Figure 64. Japan Tasimelteon Market Size 2027-2032 ($ millions)
Figure 65. Korea Tasimelteon Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Tasimelteon Market Size 2027-2032 ($ millions)
Figure 67. India Tasimelteon Market Size 2027-2032 ($ millions)
Figure 68. Australia Tasimelteon Market Size 2027-2032 ($ millions)
Figure 69. Germany Tasimelteon Market Size 2027-2032 ($ millions)
Figure 70. France Tasimelteon Market Size 2027-2032 ($ millions)
Figure 71. UK Tasimelteon Market Size 2027-2032 ($ millions)
Figure 72. Italy Tasimelteon Market Size 2027-2032 ($ millions)
Figure 73. Russia Tasimelteon Market Size 2027-2032 ($ millions)
Figure 74. Egypt Tasimelteon Market Size 2027-2032 ($ millions)
Figure 75. South Africa Tasimelteon Market Size 2027-2032 ($ millions)
Figure 76. Israel Tasimelteon Market Size 2027-2032 ($ millions)
Figure 77. Turkey Tasimelteon Market Size 2027-2032 ($ millions)
Figure 78. Global Tasimelteon Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Tasimelteon Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Tasimelteon Market Size 2027-2032 ($ millions)
